AnHorn Medicines announced that it has received $10 million in a round of funding led by new investor Taiwania Capital Management Corporation on April 25, 2023. The transaction included participation from new investors TaiAn Technologies Corporation, Industrial Technology Investment Corporation, Hong Tai Electric Industrial Co., Ltd., Black Marble Capital Management Co., Ltd., Sunplus Technology Company Limited, and Mega Venture Capital Co., Ltd.